3M Solid Microstructured Transdermal System Technology
The 3M Solid Microstructured Transdermal System (sMTS) is a state-of-the-art solid microneedle system for transcutaneous or intra-dermal drug delivery. sMTS bypasses the barrier properties of the stratum corneum and provides a means to deliver a variety of molecules both locally and systemically that ordinarily would not penetrate the skin, including vaccines. sMTS enhances the efficacy of vaccines by targeting the antigen presenting cells within the skin, thereby improving delivery efficiency and reducing dose requirements.
sMTS offers several key benefits for our partners and patients alike:
- Expands the range of molecules that can be delivered transdermally
- Potentially improves delivery efficiency and reduces dose requirements for vaccines
- Eliminates sharps hazard
- Minimal pain
- Provides product differentiation
sMTS coupled with a vaccine and our
innovative adjuvant technology allows 3M to supply an integrated adjuvant/delivery system for further product differentiation.
